About this Research Topic
Reviews in Gastrointestinal and Hepatic Pharmacology: 2024 will publish high-quality scholarly review papers on key topics in Gastrointestinal and Hepatic Pharmacology. It aims to highlight recent progress in the field, whilst emphasizing important directions and new possibilities for future inquiries. We anticipate the research presented will promote discussion in the Gastrointestinal and Hepatic Pharmacology community that will translate to best practice applications in clinical, public health and policy settings.
The Reviews in Gastrointestinal and Hepatic Pharmacology: 2024 collection welcomes full-length, mini or systematic review papers, focusing on, but are not limited to, the following topics:
• Novel therapeutic approaches including innovative drug classes, such as biologics, small molecules, and gene therapies, as well as their mechanisms of action and therapeutic potential.
• Precision medicine and personalized therapeutics including advances in biomarker identification, genetic testing, and individualized treatment strategies.
• Drug safety, adverse effects, drug-drug interactions, and strategies for risk mitigation. Through comprehensive risk-benefit assessments, clinicians will gain valuable insights into optimizing therapeutic regimens while minimizing patient harm.
• Future landscape of gastrointestinal and hepatic pharmacology, identifying emerging trends, technological advancements, and unmet clinical needs. the management of gastrointestinal and hepatic disorders.
Keywords: Collection Series, Review Articles, Gastrointestinal Disorders, Hepatic Disorders, Pharmacological Interventions
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.